1991
DOI: 10.1007/bf00841163
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of interleukin 2 formation by immunomodulating peptides and its possible mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1996
1996
1996
1996

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…The choice of luliberin is based on the fact that it is synthesized not only in hypothalamus, but also in T cells [3]. Tests for antitumor activity showed that L1 and L2 peptides inhibit tumor growth by 40 and 80%, respectively.Previously, we showed that L1 specifically interacts in vitro with the promoter of bovine IL-2 gene and stimulates the production of IL-2-1ike growth factor in a culture of surviving mouse splenic T cells (lymphoblastic transformation data) [2]. The ability of L2 to interact with the promoter of human IL-2 gene was demonstrated by binding to the promoter of digoxin-labeled tL-2 DNA on a nitrocellulose membrane [ 1 ].…”
mentioning
confidence: 97%
“…The choice of luliberin is based on the fact that it is synthesized not only in hypothalamus, but also in T cells [3]. Tests for antitumor activity showed that L1 and L2 peptides inhibit tumor growth by 40 and 80%, respectively.Previously, we showed that L1 specifically interacts in vitro with the promoter of bovine IL-2 gene and stimulates the production of IL-2-1ike growth factor in a culture of surviving mouse splenic T cells (lymphoblastic transformation data) [2]. The ability of L2 to interact with the promoter of human IL-2 gene was demonstrated by binding to the promoter of digoxin-labeled tL-2 DNA on a nitrocellulose membrane [ 1 ].…”
mentioning
confidence: 97%